Logo image of CELH

CELSIUS HOLDINGS INC (CELH) Stock Fundamental Analysis

NASDAQ:CELH - Nasdaq - US15118V2079 - Common Stock - Currency: USD

37.24  +0.58 (+1.58%)

After market: 37.53 +0.29 (+0.78%)

Fundamental Rating

5

Taking everything into account, CELH scores 5 out of 10 in our fundamental rating. CELH was compared to 32 industry peers in the Beverages industry. CELH has an excellent financial health rating, but there are some minor concerns on its profitability. CELH shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CELH was profitable.
CELH had a positive operating cash flow in the past year.
CELH had positive earnings in 4 of the past 5 years.
CELH had a positive operating cash flow in 4 of the past 5 years.
CELH Yearly Net Income VS EBIT VS OCF VS FCFCELH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

With a decent Return On Assets value of 6.08%, CELH is doing good in the industry, outperforming 65.63% of the companies in the same industry.
The Return On Equity of CELH (8.78%) is comparable to the rest of the industry.
CELH's Return On Invested Capital of 8.45% is in line compared to the rest of the industry. CELH outperforms 59.38% of its industry peers.
Industry RankSector Rank
ROA 6.08%
ROE 8.78%
ROIC 8.45%
ROA(3y)0.55%
ROA(5y)1.88%
ROE(3y)0.83%
ROE(5y)2.49%
ROIC(3y)N/A
ROIC(5y)N/A
CELH Yearly ROA, ROE, ROICCELH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

With a Profit Margin value of 7.93%, CELH perfoms like the industry average, outperforming 56.25% of the companies in the same industry.
In the last couple of years the Profit Margin of CELH has declined.
The Operating Margin of CELH (11.49%) is comparable to the rest of the industry.
CELH has a Gross Margin (50.18%) which is in line with its industry peers.
In the last couple of years the Gross Margin of CELH has grown nicely.
Industry RankSector Rank
OM 11.49%
PM (TTM) 7.93%
GM 50.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y85.55%
PM growth 5Y-9.85%
GM growth 3Y7.15%
GM growth 5Y3.78%
CELH Yearly Profit, Operating, Gross MarginsCELH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

8

2. Health

2.1 Basic Checks

CELH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CELH has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CELH has more shares outstanding
Compared to 1 year ago, CELH has a worse debt to assets ratio.
CELH Yearly Shares OutstandingCELH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CELH Yearly Total Debt VS Total AssetsCELH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 12.40 indicates that CELH is not in any danger for bankruptcy at the moment.
CELH's Altman-Z score of 12.40 is amongst the best of the industry. CELH outperforms 87.50% of its industry peers.
The Debt to FCF ratio of CELH is 0.00, which is an excellent value as it means it would take CELH, only 0.00 years of fcf income to pay off all of its debts.
CELH has a Debt to FCF ratio of 0.00. This is amongst the best in the industry. CELH outperforms 93.75% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that CELH is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, CELH belongs to the top of the industry, outperforming 90.63% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.4
ROIC/WACC0.94
WACC8.98%
CELH Yearly LT Debt VS Equity VS FCFCELH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

CELH has a Current Ratio of 3.62. This indicates that CELH is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 3.62, CELH belongs to the best of the industry, outperforming 96.88% of the companies in the same industry.
CELH has a Quick Ratio of 3.26. This indicates that CELH is financially healthy and has no problem in meeting its short term obligations.
CELH has a better Quick ratio (3.26) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.62
Quick Ratio 3.26
CELH Yearly Current Assets VS Current LiabilitesCELH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

7

3. Growth

3.1 Past

CELH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -43.10%.
The Earnings Per Share has been growing by 55.36% on average over the past years. This is a very strong growth
Looking at the last year, CELH shows a small growth in Revenue. The Revenue has grown by 2.85% in the last year.
The Revenue has been growing by 78.36% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-43.1%
EPS 3Y22.39%
EPS 5Y55.36%
EPS Q2Q%-164.71%
Revenue 1Y (TTM)2.85%
Revenue growth 3Y62.78%
Revenue growth 5Y78.36%
Sales Q2Q%-4.39%

3.2 Future

Based on estimates for the next years, CELH will show a very strong growth in Earnings Per Share. The EPS will grow by 37.50% on average per year.
Based on estimates for the next years, CELH will show a quite strong growth in Revenue. The Revenue will grow by 16.25% on average per year.
EPS Next Y115.88%
EPS Next 2Y60.28%
EPS Next 3Y44.23%
EPS Next 5Y37.5%
Revenue Next Year37.94%
Revenue Next 2Y27.56%
Revenue Next 3Y20.58%
Revenue Next 5Y16.25%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CELH Yearly Revenue VS EstimatesCELH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
CELH Yearly EPS VS EstimatesCELH Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 84.64, which means the current valuation is very expensive for CELH.
CELH's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 28.29. CELH is valued rather expensively when compared to this.
CELH is valuated quite expensively with a Price/Forward Earnings ratio of 39.21.
CELH's Price/Forward Earnings is on the same level as the industry average.
CELH's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.08.
Industry RankSector Rank
PE 84.64
Fwd PE 39.21
CELH Price Earnings VS Forward Price EarningsCELH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

CELH's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CELH is more expensive than 68.75% of the companies in the same industry.
CELH's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 40.05
EV/EBITDA 53.39
CELH Per share dataCELH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

CELH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CELH's earnings are expected to grow with 44.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.73
PEG (5Y)1.53
EPS Next 2Y60.28%
EPS Next 3Y44.23%

0

5. Dividend

5.1 Amount

CELH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CELSIUS HOLDINGS INC

NASDAQ:CELH (4/17/2025, 8:07:25 PM)

After market: 37.53 +0.29 (+0.78%)

37.24

+0.58 (+1.58%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners63.72%
Inst Owner Change-0.01%
Ins Owners20.46%
Ins Owner Change0.68%
Market Cap9.59B
Analysts80
Price Target40.12 (7.73%)
Short Float %20.85%
Short Ratio3.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP25.59%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-149.28%
Min EPS beat(2)-198.57%
Max EPS beat(2)-100%
EPS beat(4)2
Avg EPS beat(4)-62.02%
Min EPS beat(4)-198.57%
Max EPS beat(4)36.12%
EPS beat(8)6
Avg EPS beat(8)1.19%
EPS beat(12)8
Avg EPS beat(12)-19.66%
EPS beat(16)11
Avg EPS beat(16)6.19%
Revenue beat(2)1
Avg Revenue beat(2)-1.23%
Min Revenue beat(2)-2.46%
Max Revenue beat(2)0.01%
Revenue beat(4)2
Avg Revenue beat(4)-3.19%
Min Revenue beat(4)-10.55%
Max Revenue beat(4)0.24%
Revenue beat(8)6
Avg Revenue beat(8)3.76%
Revenue beat(12)9
Avg Revenue beat(12)4.8%
Revenue beat(16)13
Avg Revenue beat(16)8.04%
PT rev (1m)0.91%
PT rev (3m)-2.57%
EPS NQ rev (1m)-3.05%
EPS NQ rev (3m)-16.9%
EPS NY rev (1m)2.69%
EPS NY rev (3m)0.42%
Revenue NQ rev (1m)-1.45%
Revenue NQ rev (3m)-7.25%
Revenue NY rev (1m)4.79%
Revenue NY rev (3m)18.54%
Valuation
Industry RankSector Rank
PE 84.64
Fwd PE 39.21
P/S 7.08
P/FCF 40.05
P/OCF 36.49
P/B 7.83
P/tB 8.41
EV/EBITDA 53.39
EPS(TTM)0.44
EY1.18%
EPS(NY)0.95
Fwd EY2.55%
FCF(TTM)0.93
FCFY2.5%
OCF(TTM)1.02
OCFY2.74%
SpS5.26
BVpS4.75
TBVpS4.43
PEG (NY)0.73
PEG (5Y)1.53
Profitability
Industry RankSector Rank
ROA 6.08%
ROE 8.78%
ROCE 11.11%
ROIC 8.45%
ROICexc 23.17%
ROICexgc 27.72%
OM 11.49%
PM (TTM) 7.93%
GM 50.18%
FCFM 17.67%
ROA(3y)0.55%
ROA(5y)1.88%
ROE(3y)0.83%
ROE(5y)2.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y85.55%
PM growth 5Y-9.85%
GM growth 3Y7.15%
GM growth 5Y3.78%
F-Score5
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 321.56%
Cap/Sales 1.73%
Interest Coverage 250
Cash Conversion 161.29%
Profit Quality 222.89%
Current Ratio 3.62
Quick Ratio 3.26
Altman-Z 12.4
F-Score5
WACC8.98%
ROIC/WACC0.94
Cap/Depr(3y)425.65%
Cap/Depr(5y)315.78%
Cap/Sales(3y)1.44%
Cap/Sales(5y)1.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.1%
EPS 3Y22.39%
EPS 5Y55.36%
EPS Q2Q%-164.71%
EPS Next Y115.88%
EPS Next 2Y60.28%
EPS Next 3Y44.23%
EPS Next 5Y37.5%
Revenue 1Y (TTM)2.85%
Revenue growth 3Y62.78%
Revenue growth 5Y78.36%
Sales Q2Q%-4.39%
Revenue Next Year37.94%
Revenue Next 2Y27.56%
Revenue Next 3Y20.58%
Revenue Next 5Y16.25%
EBIT growth 1Y-43.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year71.41%
EBIT Next 3Y36.17%
EBIT Next 5Y25.11%
FCF growth 1Y93.49%
FCF growth 3YN/A
FCF growth 5Y205.5%
OCF growth 1Y86.16%
OCF growth 3YN/A
OCF growth 5Y204.76%